Evidence map›Paper›PMID 41807765›Full record

ArticleMedical physics2026

Out-of-beam artifact suppression in charged nuclear fragment based carbon-ion radiotherapy monitoring.

Rebekka Kirchgässner, Mária Martišíková, Patrice Schlegel, Pamela Ochoa-Parra, Semi Harrabi, Oliver Jäkel, Jürgen Debus, Laurent Kelleter

Abstract read
In one paragraph

Article in Medical physics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Rebekka KirchgässnerHeidelberg Institute for Radiation Oncology (HIRO) and National Center for Radiation Research in oncology (NCRO), Heidelberg, Germany.
Mária MartišíkováHeidelberg Institute for Radiation Oncology (HIRO) and National Center for Radiation Research in oncology (NCRO), Heidelberg, Germany.
Patrice SchlegelHeidelberg Institute for Radiation Oncology (HIRO) and National Center for Radiation Research in oncology (NCRO), Heidelberg, Germany.
Pamela Ochoa-ParraHeidelberg Institute for Radiation Oncology (HIRO) and National Center for Radiation Research in oncology (NCRO), Heidelberg, Germany.
Semi HarrabiNational Center of Tumor Diseases (NCT), DKFZ and University Medical Center, Heidelberg, Germany.
Oliver JäkelHeidelberg Institute for Radiation Oncology (HIRO) and National Center for Radiation Research in oncology (NCRO), Heidelberg, Germany.
Jürgen DebusNational Center of Tumor Diseases (NCT), DKFZ and University Medical Center, Heidelberg, Germany.
Laurent KelleterHeidelberg Institute for Radiation Oncology (HIRO) and National Center for Radiation Research in oncology (NCRO), Heidelberg, Germany.

Funding

Helmholtz Information and Data Science School for HealthNationales Centrum für Tumorerkrankungen HeidelbergStudienstiftung des Deutschen Volkes
6 · The paper itself

Abstract

backgroundCarbon-ion radiotherapy offers highly precise targeting of tumors while sparing healthy tissue compared to X-ray therapy. However, this precision comes at the cost of an increased sensitivity of the treatment to range uncertainties, which can arise from anatomical changes of the patient. Our group develops an in-vivo treatment monitoring method by tracking of charged nuclear fragments using hybrid silicon pixel detectors. PURPOSE: Anatomical changes outside of the region accessed by carbon-ion beams are clinically not relevant, as they do not affect the dose distribution. However, they can potentially influence the fragment data, producing artifacts, which might be interpreted as signals produced by clinically relevant anatomical changes. This misinterpretation would cause unnecessary clinical action, like performing a CT scan. This work proposes methods for the identification and suppression of clinically irrelevant artifacts with the aim of avoiding unnecessary clinical action.

methodsA clinically relevant and an irrelevant anatomical change are emulated by introducing coin-sized air cavities at different positions in a homogeneous cylindrical plastic head phantom. Charged nuclear fragments are detected by a Timepix3-based mini-tracker during irradiations of this phantom with a clinically realistic treatment plan. All measurements are performed for two different positions of the mini-tracker. The reconstructed fragmentation vertex distributions are analyzed and compared to those of reference measurements.

resultsA significant signal from the clinically irrelevant air cavity was observed. This artifact was found to differ from the signal of the clinically relevant cavity. Most importantly, the location of the artifact changes with the mini-tracker position, whereas the relevant signal remains unchanged. This facilitates identification of the artifact as well as its suppression by combining the data from several mini-trackers at different positions around the patient.

conclusionsClinically irrelevant changes were shown to potentially impede carbon-ion treatment monitoring by tracking of charged nuclear fragments. However, positioning several mini-trackers around the patient, which monitor the treatment from different perspectives, was found to be the key to the identification and suppression of artifacts from anatomical changes outside of the region accessed by carbon-ion beams. This is implemented in the detection system of an ongoing clinical trial.

Indexed as

ArtifactsHeavy Ion RadiotherapyHumansPhantoms, Imagingcarbon‐ion therapy monitoringsecondary ion trackingTimepix3

Identifiers

PMID41807765
PMCPMC12975665

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.